446 related articles for article (PubMed ID: 3882831)
21. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
22. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
23. Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines.
de Landazuri MO; López-Botet M; Timonen T; Ortaldo JR; Herberman RB
J Immunol; 1981 Oct; 127(4):1380-3. PubMed ID: 6168686
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
25. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
26. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
27. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
Knoblock KF; Canning PC
Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
[TBL] [Abstract][Full Text] [Related]
28. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
Gersuk GM; Chang WC; Pattengale PK
J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
33. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
Suzuki R; Handa K; Itoh K; Kumagai K
J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
[TBL] [Abstract][Full Text] [Related]
34. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
35. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
36. Chemotaxis of large granular lymphocytes.
Pohajdak B; Gomez J; Orr FW; Khalil N; Talgoy M; Greenberg AH
J Immunol; 1986 Jan; 136(1):278-84. PubMed ID: 2999245
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
Rolstad B; Fossum S
Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
[TBL] [Abstract][Full Text] [Related]
38. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
[TBL] [Abstract][Full Text] [Related]
40. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]